Table 4:
Factors associated with risk of death among the entire cohort.
Univariate | Multivariable | |||||
---|---|---|---|---|---|---|
Variable | HR | 95% CI | P-value | HR | 95% CI | P-value |
Recipient age (LDLT) | 1.03 | 1.01–1.04 | <0.001 | 1.02 | 1.01–1.03 | <0.001 |
MELD (LDLT) | 1.02 | 1.00–1.04 | 0.025 | --- | ||
Creatinine (LDLT) | 1.36 | 1.19–1.16 | <0.001 | 1.37 | 1.20–1.56 | <0.001 |
Female sex | 0.77 | 0.60–0.99 | 0.04 | --- | ||
HCV | 1.60 | 1.26–2.03 | <0.001 | 1.32 | 1.03–1.70 | 0.03 |
HCC | 1.73 | 1.29–2.33 | <0.001 | 1.40 | 1.02–1.91 | 0.04 |
Ethnicity | 0.99 | 0.70–1.38 | 0.94 | --- | ||
Left lobe | 1.12 | 0.64–1.96 | 0.69 | |||
LOS | 1.02 | 1.01–1.02 | <0.001 | 1.01 | 1.01–1.02 | <0.001 |
Bile leak | 1.21 | 0.93–1.58 | 0.16 | |||
Biliary stricture | 1.12 | 0.84–1.50 | 0.45 | |||
HAT | 2.63 | 1.75–3.96 | <0.001 | 1.69 | 1.05–2.72 | 0.03 |
Disease recurrence | 1.70 | 0.95–3.06 | 0.075 | |||
Pulmonary Infection | 2.28 | 1.56–3.34 | <0.01 | 1.68 | 1.13–2.5 | 0.01 |
Re-LT | 3.56 | 2.60–4.89 | <0.001 | 2.29 | 1.55–3.39 | <0.001 |